Masami Miki

CLEC3A, MMP7, and LCN2 as novel markers for predicting recurrence in resected G1 and G2 pancreatic neuroendocrine tumors

Masami Miki, Takamasa Oono, Nao Fujimori et al. · Cancer Medicine · 2019 · 27 citations · Full text

Natural history and clinical outcomes of pancreatic neuroendocrine neoplasms based on the WHO 2017 classification; a single-center experience of 30 years

Nao Fujimori, Masami Miki, Lingaku Lee et al. · Pancreatology · 2020 · 18 citations

Endocrine Oncology, Pancreatic Cancer, Surgical Pathology +5

Treatment Effect and Safety of Nanoliposomal Irinotecan with Fluorouracil and Folinic Acid after Gemcitabine-Based Therapy in Patients with Advanced Pancreatic Cancer: A Multicenter, Prospective Observational Study

Masami Miki, Nao Fujimori, Keijiro Ueda et al. · Journal of Clinical Medicine · 2022 · 17 citations · Full text

Cancer Management, Treatment Effect, Pharmacotherapy +17

Utility of chromogranin B compared with chromogranin A as a biomarker in Japanese patients with pancreatic neuroendocrine tumors

Masami Miki, Tetsuhide Ito, Masayuki Hijioka et al. · Japanese Journal of Clinical Oncology · 2017 · 16 citations · Full text

Relapse patterns and predictors of IgG4‐related diseases involved with autoimmune pancreatitis: A single‐center retrospective study of 115 patients

Masami Miki, Nao Fujimori, Takamasa Oono et al. · Journal of Digestive Diseases · 2019 · 16 citations